Fujian Aonong Biological Technology Group Incorporation Limited

SHSE:603363 Stock Report

Market Cap: CN¥3.1b

Fujian Aonong Biological Technology Group Incorporation Future Growth

Future criteria checks 5/6

Fujian Aonong Biological Technology Group Incorporation is forecast to grow earnings and revenue by 130.2% and 44.9% per annum respectively while EPS is expected to grow by 130.1% per annum.

Key information

130.2%

Earnings growth rate

130.1%

EPS growth rate

Food earnings growth25.7%
Revenue growth rate44.9%
Future return on equityn/a
Analyst coverage

Low

Last updated18 Jul 2023

Recent future growth updates

Recent updates

Fujian Aonong Biological Technology Group Incorporation Limited's (SHSE:603363) Shares Not Telling The Full Story

Aug 22
Fujian Aonong Biological Technology Group Incorporation Limited's (SHSE:603363) Shares Not Telling The Full Story

Market Cool On Fujian Aonong Biological Technology Group Incorporation Limited's (SHSE:603363) Revenues Pushing Shares 30% Lower

May 02
Market Cool On Fujian Aonong Biological Technology Group Incorporation Limited's (SHSE:603363) Revenues Pushing Shares 30% Lower

Earnings and Revenue Growth Forecasts

SHSE:603363 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202534,5231,3622,0053,1411
12/31/202431,9901,4691,6732,5881
6/30/202414,047-3,382450811N/A
3/31/202417,048-3,763275703N/A
12/31/202319,458-3,651472984N/A
9/30/202321,387-1,7565631,307N/A
6/30/202322,862-1,1711231,211N/A
3/31/202322,276-866-534783N/A
12/31/202221,613-1,038-835664N/A
9/30/202220,119-1,590-1,408201N/A
6/30/202218,636-2,034-1,39487N/A
3/31/202218,299-2,034-1,344609N/A
12/31/202118,038-1,520-2,184524N/A
9/30/202117,504-432-2,500912N/A
6/30/202115,64972-3,375791N/A
3/31/202113,663584-3,719413N/A
12/31/202011,517573-2,887406N/A
9/30/20208,860491-2,34950N/A
6/30/20207,165346-1,414104N/A
3/31/20206,197163-532339N/A
12/31/20195,78829-264394N/A
9/30/20195,79439-267256N/A
6/30/20195,73635-237248N/A
3/31/20195,74633-151297N/A
12/31/20185,76230-54227N/A
9/30/20185,67549-714-95N/A
6/30/20185,37661-766-136N/A
3/31/20185,13799N/A-66N/A
12/31/20174,903108N/A42N/A
9/30/20174,960119N/A158N/A
12/31/20164,97891N/A129N/A
12/31/20154,01334N/A129N/A
12/31/20144,18443N/A-34N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 603363 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.9%).

Earnings vs Market: 603363 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: 603363 is expected to become profitable in the next 3 years.

Revenue vs Market: 603363's revenue (44.9% per year) is forecast to grow faster than the CN market (13.2% per year).

High Growth Revenue: 603363's revenue (44.9% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 603363's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y